This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $100,000
Oncolytic Virus Immunotherapy for Brain Cancer
CIHR · 2014 · Co-investigator
- $160,000
Chimeric Oncolytic Virus for Brain Cancer Treatment
CIHR · 2013 · Co-investigator
- $50,000
Program Overview: The Terry Fox New Frontiers Program Project in Cancer Research. Canadian Oncolytic Virus Consortium (Dr. John Bell)
CIHR · 2012 · Principal investigator
Oncolytic Virus Immunotherapy for Brain Cancer
Principal investigators: Stojdl, David F
Keywords: Brain Cancer; Immunotherapy; Oncolytic Virus; Therapeutics
Chimeric Oncolytic Virus for Brain Cancer Treatment
Principal investigators: Stojdl, David F
Keywords: Biotherapeutics; Brain Cancer; Cancer Therapy; Commercialization; Manufacturing; Oncolytic Virus; Process Development
Program Overview: The Terry Fox New Frontiers Program Project in Cancer Research. Canadian Oncolytic Virus Consortium (Dr. John Bell)
Principal investigators: Bell, John C; Bramson, Jonathan L; Diallo, Jean-Simon; Lee, Patrick W; Lichty, Brian D; Mccart, Judith A; Sonenberg, Nahum; Stojdl, David F
Keywords: Anti Tumour Immunity; Cancer Cell Signalling; Cancer Therapeutics; Genetic Engineering; Innate Antiviral Immunity; Oncolytic Virus; Tumour Microenvironment; Tumour Vasculature
Development of a Therapeutic Oncolytic Poxvirus with Enhanced Systemic Delivery and Potency
Principal investigators: Bell, John C
Keywords: Biotherapeutics; Cancer Therapy; Genetic Engineering; Imaging; Molecular Biology; Oncolytic Virus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.